Back to CVE records
Medium 6.5Published Mar 7, 2026

CVE-2026-29781Sliver is a command and control framework that uses a custom Wireguard netstack.

Updated under an hour ago ()

Does this affect you?

It affects bishopfox sliver. Add what you run to find out whether that includes you.

No exploitation reported and no EPSS estimate yet.

Sliver is a command and control framework that uses a custom Wireguard netstack. In versions from 1.7.3 and prior, a vulnerability exists in the Sliver C2 server's Protobuf unmarshalling logic due to a systemic lack of nil-pointer validation. By extracting valid implant credentials and omitting nested fields in a signed message, an authenticated actor can trigger an unhandled runtime panic. Because the mTLS, WireGuard, and DNS transport layers lack the panic recovery middleware present in the HTTP transport, this results in a global process termination. While requiring post-authentication access (a captured implant), this flaw effectively acts as an infrastructure "kill-switch," instantly severing all active sessions across the entire fleet and requiring a manual server restart to restore operations. At time of publication, there are no publicly available patches.

CVSS
6.5 MEDIUM (v3.1, NVD)CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:H
Weakness (CWE)
CWE-476
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
Not loaded for this CVE
Assigned by
Not given
NVD analysis
Analyzed
Record last updated
Jun 17, 2026
First seen by InfoSec Signals
Oct 9, 2026

Affected products

Affected products
bishopfox sliver
bishopfox:sliver
through 1.7.3
NVD

References

  • exploit, mitigation, vendor-advisory

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.